227 related articles for article (PubMed ID: 26566061)
1. Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.
Martin DJ; Weideman R; Crook T; Brown G
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):181-6. PubMed ID: 26566061
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of gallbladder disease among persons with hepatitis C virus infection in the United States.
Bini EJ; McGready J
Hepatology; 2005 May; 41(5):1029-36. PubMed ID: 15770666
[TBL] [Abstract][Full Text] [Related]
3. Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection.
Yu L; Morishima C; Ioannou GN
Br J Nutr; 2016 Jan; 115(2):193-201. PubMed ID: 26541123
[TBL] [Abstract][Full Text] [Related]
4. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
[TBL] [Abstract][Full Text] [Related]
5. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.
Stroffolini T; Sagnelli E; Mele A; Cottone C; Almasio PL;
J Viral Hepat; 2007 Sep; 14(9):618-23. PubMed ID: 17697013
[TBL] [Abstract][Full Text] [Related]
6. Liver fibrosis progression in hepatitis C virus infection after seroconversion.
Butt AA; Yan P; Lo Re V; Rimland D; Goetz MB; Leaf D; Freiberg MS; Klein MB; Justice AC; Sherman KE;
JAMA Intern Med; 2015 Feb; 175(2):178-85. PubMed ID: 25485735
[TBL] [Abstract][Full Text] [Related]
7. Study of liver cirrhosis over ten consecutive years in Southern China.
Wang X; Lin SX; Tao J; Wei XQ; Liu YT; Chen YM; Wu B
World J Gastroenterol; 2014 Oct; 20(37):13546-55. PubMed ID: 25309085
[TBL] [Abstract][Full Text] [Related]
8. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
11. Prospective cohort study on the outcomes of hepatitis C virus-related cirrhosis in South Korea.
Lee SS; Jeong SH; Jang ES; Kim YS; Lee YJ; Jung EU; Kim IH; Bae SH; Lee HC; Kee MK; Kang C
J Gastroenterol Hepatol; 2015 Aug; 30(8):1281-7. PubMed ID: 25778783
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic cholecystectomy is the preferred approach in cirrhosis: a nationwide, population-based study.
Chmielecki DK; Hagopian EJ; Kuo YH; Kuo YL; Davis JM
HPB (Oxford); 2012 Dec; 14(12):848-53. PubMed ID: 23134187
[TBL] [Abstract][Full Text] [Related]
14. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
[TBL] [Abstract][Full Text] [Related]
15. Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis C: analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial.
Yu L; Morishima C; Ioannou GN
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1661-6.e1-3. PubMed ID: 23707779
[TBL] [Abstract][Full Text] [Related]
16. Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters.
van der Meer AJ; Hansen BE; Fattovich G; Feld JJ; Wedemeyer H; Dufour JF; Lammert F; Duarte-Rojo A; Manns MP; Ieluzzi D; Zeuzem S; Hofmann WP; de Knegt RJ; Veldt BJ; Janssen HL
Gut; 2015 Feb; 64(2):322-31. PubMed ID: 24815676
[TBL] [Abstract][Full Text] [Related]
17. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
18. [Rate of liver fibrosis progression among patients with chronic hepatitis C in Poland].
Kryczka W; Chrapek M; Paluch K; Zarebska-Michaluk D; Urbaniak A
Pol Arch Med Wewn; 2003 Aug; 110(2):869-75. PubMed ID: 14682226
[TBL] [Abstract][Full Text] [Related]
19. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients.
Nkontchou G; Cosson E; Aout M; Mahmoudi A; Bourcier V; Charif I; Ganne-Carrie N; Grando-Lemaire V; Vicaut E; Trinchet JC; Beaugrand M
J Clin Endocrinol Metab; 2011 Aug; 96(8):2601-8. PubMed ID: 21752887
[TBL] [Abstract][Full Text] [Related]
20. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]